Onkure Therapeutics

Developer of epigenetic therapies for the treatment of cancer.

placeLongmont, Colorado, United States calendar_todayFounded 2011 groups35 employees language onkuretherapeutics.com

Registered entities

Social engagement

Social engagement: 4.2K social following, 6 posts in the last 12 months — below the industry typical range.

Investor mix

10 investors on record; lead investors include Acorn Bioventures, Surveyor Capital, Delian Capital.

Investor typeCountShare
Venture capital550%
Private equity110%
Other / undisclosed440%

Hiring activity

Hires occasionally

2 roles tracked across 1 of the last 12 months

30 Apr 2026 · Director/Senior Director, Analytical Chemistry

Based on job postings tracked across public sources.

Recent activity

22 May 2026
Event
ISSVA World Congress 2026
19 May 2026
Event
ISSVA World Congress
Coming soon